Quarterly report pursuant to Section 13 or 15(d)

(LOSS) INCOME PER SHARE

v3.22.2.2
(LOSS) INCOME PER SHARE
9 Months Ended
Sep. 30, 2022
(LOSS) INCOME PER SHARE  
(LOSS) INCOME PER SHARE

7. (LOSS) INCOME PER SHARE

The following table sets forth the computation of basic and fully diluted (loss) income per share for the three and nine months ended September 30, 2022 and 2021 (in thousands, except per share amounts):

    

Three Months Ended September 30, 

Nine Months Ended September 30, 

2022

    

2021

2022

    

2021

Net (loss) income

$

(1,433)

$

91

$

(8,618)

$

(2,447)

Basic weighted average common stock outstanding

 

15,220,948

 

11,838,032

 

13,686,686

 

11,528,371

Basic loss per share

$

(0.09)

$

0.01

$

(0.63)

$

(0.21)

Net (loss) income

$

(1,433)

$

91

$

(8,618)

$

(2,447)

Basic weighted average common shares outstanding

 

15,220,948

 

11,838,032

 

13,686,686

 

11,528,371

Dilutive effect of stock options and warrants

 

 

3,886,071

 

 

Dilutive weighted average common stock outstanding

 

15,220,948

 

15,724,103

 

13,686,686

 

11,528,371

Diluted loss per share

$

(0.09)

$

0.01

$

(0.63)

$

(0.21)

Basic net income (loss) per share is computed using the weighted average number of common shares outstanding during the period. Diluted net income (loss) per share is computed using the treasury stock method to calculate the weighted average number of common shares and, if dilutive, potential common shares outstanding during the period. Potential dilutive common shares include incremental common shares issuable upon the exercise of stock options, less shares from assumed proceeds. The assumed proceeds calculation includes actual proceeds to be received from the employee upon exercise and the average unrecognized stock compensation cost during the period

Stock options to purchase 882,582 and 227,893 shares of common stock and warrants to purchase 3,940,006 and 462,068 shares of common stock were outstanding at September 30, 2022 and 2021 that were not included in the computation of diluted weighted average common stock outstanding because their effect would have been anti-dilutive.